Close Menu
Arogidigba Global JournalArogidigba Global Journal
  • Home
  • Latest News
  • National
  • Politics
  • Entertainment
  • Sports

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Senate divided over bill to end exploitation of low-income workers

May 22, 2025

NAAT rejects N50bn earned allowance, declares trade dispute

May 22, 2025

Philanthropist launches emergency water initiative in Sokoto

May 22, 2025
Facebook X (Twitter) Instagram WhatsApp Telegram
  • About Us
  • Advert Rate
  • Get In Touch
Facebook X (Twitter) Instagram WhatsApp Telegram
Arogidigba Global JournalArogidigba Global Journal
  • Home
  • Latest News
  • National
  • Politics
  • Entertainment
  • Sports
Subscribe
Facebook X (Twitter) Instagram WhatsApp Telegram
Arogidigba Global JournalArogidigba Global Journal
You are at:Home»Featured»WHO warns of growing resistance to first-line HIV drug
Featured

WHO warns of growing resistance to first-line HIV drug

March 6, 2024No Comments3 Mins Read
Facebook Twitter Telegram LinkedIn WhatsApp Email Copy Link
Share
Facebook Twitter LinkedIn Email Telegram WhatsApp

Resistance to a widely used HIV drug is growing among patients, the World Health Organization (WHO) has warned, sparking concern among scientists.

Dolutegravir has been recommended by the WHO as the preferred first-line treatment for HIV since 2018 and is currently used by more than 24 million patients worldwide.

However, it now appears the effectiveness of the medication is beginning to wane in users as the HIV virus grows resistant to the drug, according to a new report published by the WHO. 

Dolutegravir is an antiretroviral medicine and is used in combination with other drugs to reduce the amount of virus in the body to an undetectable level. Although not a cure, it is effective in preventing the development of serious illness, as well as further transmission.

However, like other viruses, bacteria, and fungi, HIV has genetically adapted over time to circumvent the drugs used to treat it – meaning that, in some patients, the drug becomes either partially or completely ineffective, increasing the risk of disease and death. 

Ravindra Gupta, Professor of Clinical Microbiology at the University of Cambridge, said the WHO’s findings were “concerning”. 

“It’s a call to action to strengthen surveillance in order to preserve the utility of the drug,” he said.

“Dolutegravir is very potent and effective, and so it was expected that there would be little to no resistance when it was first introduced.”

‘Worrying’ data

The WHO conducted research in Malawi, Mozambique, Ukraine, and Uganda, and found that resistance to dolutegravir ranged from around four to 20 per cent among patients surveyed. 

The data is “worrying evidence” that drug resistance is “growing,” the organisation said. 

The WHO said that routine surveillance of HIV mutations in patients receiving antiviral therapy is needed to help understand the patterns of resistance.

Currently, only 12 of the 45 countries identified by the WHO as HIV prevalent have reported routine monitoring of drug resistance. 

“We agree with the WHO that there is a need for further surveillance,” said a spokesperson from British pharmaceutical company GSK, which manufactures the drug.

“The resistance analysis focuses on subgroups whose virus was not suppressed and the data does not indicate that resistance was prevalent in the overall population,” the spokesperson added, however. 

Dolutegravir is more effective, easier to take and has fewer side effects than other HIV drugs currently in use. It also has a high genetic barrier to developing drug resistance.

According to the WHO, drug resistance kills 4.9 million every year globally, and it’s estimated this number will rise to 10 million by 2050 as viruses, bacteria and other pathogens further evolve to evade modern medicine.

Protect yourself and your family by learning more about Global Health Security

Share. Facebook Twitter LinkedIn WhatsApp Email Telegram Copy Link
Previous ArticleRecruit us as state police, Constabularies appeal to Gov Makinde
Next Article Market optimism prevails as NGX ASI up by 401.18 points, market cap swells N227 billion 

Related Posts

Philanthropist launches emergency water initiative in Sokoto

May 22, 2025

NBTE grants Federal Poly Ayede full accreditation, approves new programme

May 22, 2025

50 Sokoto journalists undergo three-day training

May 21, 2025

Leave A Reply Cancel Reply

Ads />
</a></div>		</div>

		</div>
		<div id=
Latest Posts

Senate divided over bill to end exploitation of low-income workers

May 22, 20250 Views

NAAT rejects N50bn earned allowance, declares trade dispute

May 22, 20250 Views

Philanthropist launches emergency water initiative in Sokoto

May 22, 20250 Views

Protests erupt over illegal mining in FCT

May 22, 20250 Views
Don't Miss

Danish Embassy, Danish Veterinary And Food Agency, Partner NAFDAC To Combat Antimicrobial Resisitance

By Arogidigba Global JournalDecember 8, 2024

The National Agency for Food and Drug Administration and Control NAFDAC in its quest to…

CAN disburses 600 baggage of rice to Jigawa Christians

January 6, 2024

Court Nullifies Rivers 2024 Budget, Bars Fubara From Interfering In Assembly Matters

January 22, 2024

OSIEC chairmanship: I am no longer PDP member – Hashim Abioye

January 12, 2024

Senate In Rowdy Session As Lawmaker Claims ‘Older’ Senators Got N500m For Projects

March 12, 2024
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo

Subscribe to Updates

Get the latest news from Arogidigba Global Journal

About Us
About Us

AROGIDIGBA GLOBAL NEWS…something of stupendous magnitude is a digital newspaper platform published by AROGIDIGBA MEDIA LIMITED. We are accessed all over the world on the various social media. As an independent News Organization, we are purposefully positioned to serve the Nigerian audience and the world with credible news reports and shrewd analyses.

Facebook X (Twitter) YouTube WhatsApp Reddit
Latest News

Philanthropist launches emergency water initiative in Sokoto

May 22, 2025

NBTE grants Federal Poly Ayede full accreditation, approves new programme

May 22, 2025

50 Sokoto journalists undergo three-day training

May 21, 2025
Editor's Pick

Nigeria retains 56% of oil industry spend as local content deepens

May 21, 20250 Views

Reps move to boost power generation, pledge support for Egbin Power

May 21, 20250 Views

NMDPRA limits fuel trucks to 45,000 liters by Q4 2025

May 21, 20250 Views
© 2025 Arogidigba Global Journal 9v
  • Home
  • Latest News

Type above and press Enter to search. Press Esc to cancel.

Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.